BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announces that new data from NUZYRA® (omadacycline) scientific and investigator-initiated research programs will be presented at IDWeek 2023. The hybrid conference will be held from Oct. 11–15 at the Boston Convention and Exhibition Center. Access the full schedule here. All IDWeek abstracts are embargoed until Oct. 11 at 8:00 a.m. ET.
Presenter: Matthew Crotty, Pharm.D., BCIDP
Session/time/location: Oral session 264 - Skin, Bone & Joint Infections; Sat., Oct. 14, 1:45–3:00 p.m. in 102 AB Title: A Functional OMICs Evaluation of Omadacycline to Understand Anti-Clostridioides difficile Protective Effects* Presenter: Jinhee Jo, Pharm.D., BCIDP
Session/time/location: Basic Science and Translational Studies; Thurs., Oct. 12, 12:15–1:30 p.m. in BCEC Poster Hall
Presenter: Michael D. Huband, B.S.
Session/time/location: Bone and Joint; Fri., Oct. 13, 12:15–1:30 p.m. in BCEC Poster Hall
Title: High Rates of Non-Susceptibility to Common Oral Antibiotics Among Streptococcus pneumoniae Clinical Isolates from the United States (2019-2021)
Presenter: Lalitagauri Deshpande, Ph.D.
Session/time/location: Antimicrobial Novel Agents; Sat., Oct. 14, 12:15–1:30 p.m. in BCEC Poster Hall
Other Paratek Events at IDWeek 2023
Paratek invites attendees to visit the company’s onsite Booth #1024 from Oct. 11–15 and to participate in the following events: Product theater featuring guest speaker George Sakoulas, M.D., on Fri., Oct. 13, 11:15–noon in Learning Lounge 2.
Medical Affairs learning lounge presentation, "CAP in the outpatient setting: Unmet needs and current treatment challenges," featuring guest speaker Teena Chopra, M.D., M.P.H., on Sat., Oct. 14, 10:15–11:00 a.m. in Learning Lounge 2.
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. For more information, visit www.ParatekPharma.com or follow us on LinkedIn and Twitter.